United States President Donald Trump has unveiled a second deal with a major pharmaceutical company to offer lower-cost prescription drugs direct to American consumers.

This time, the agreement concerned AstraZeneca, a multinational based in the United Kingdom.

Trump hosted the company’s chief executive, Pascal Soriot, in the Oval Office on Friday to publicly cement the deal, which he described as “another historic achievement in our quest to lower drug prices for all Americans”.

“Americans can expect discounts, and as I said, it could be, in many cases, way over a hundred percent,” Trump said.

As in previous press appearances, he pledged US consumers would see impossible discounts on popular medications.

Inhalers to treat asthma, for example, would be discounted by 654 percent, Trump

See Full Page